Skip to main content

Day: April 2, 2024

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024 at 12:45 p.m. ET. A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event. About Generation Bio Generation Bio is innovating non-viral genetic medicines to provide durable and redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The company is developing two distinct...

Continue reading

Getty Images Acquires Motorsport Images, a Specialist Motorsport Archive

Brands including LAT Images, Sutton, Schlegelmilch and Dukes Video Archive to augment Getty Images’ premium motorsport offeringLONDON, April 02, 2024 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, and Motorsport Images, a specialist motorsport archive, today announced that Getty Images has acquired Motorsport Images, including its operative arm LAT Images and its Sutton, Schlegelmilch, Colombo and Dukes Video archives. With an archive of over 29 million images and more than 8,900 hours of premium video footage, Motorsport Images is the home of motoring and motorsport history, tracing its beginnings back to 1895. Between the brands Motorsport and LAT Images, as well as its Sutton, Schlegelmilch, Colombo and Dukes Video archives, Motorsport Images’ distinctive archive features...

Continue reading

Prairie Provident Resources Announces Fourth Quarter and Year-End 2023 Financial and Operating Results

CALGARY, Alberta, April 02, 2024 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident” or the “Company”) (TSX:PPR) announces its operating and financial results for the fourth quarter and year ended 2023. Prairie Provident’s audited annual consolidated financial statements and related Management’s Discussion and Analysis (MD&A) for the year ended December 31, 2023 and Annual Information Form dated April 2, 2024 for the same period are available on the Company’s website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca. 2023 ANNUAL FINANCIAL AND OPERATIONAL HIGHLIGHTSThe Company’s financial flexibility was enhanced during the year with the completion of its recapitalization and debt-for-equity settlement, under which US$53.4 million (approximately CAD$72.0 million) of indebtedness...

Continue reading

Invesco Ltd: Form 8.3 – Virgin Money UK Plc

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Virgin Money UK PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

Form 8.3 – [abrdn EUROPEAN LOGISTICS INCOME PLC – 28 03 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree abrdn EUROPEAN LOGISTICS INCOME PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Form 8.3 – DS Smith Plc.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Jupiter Fund Management Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of Offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Smith (DS) plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date dealing undertaken:        For an opening position disclosure,...

Continue reading

Icelandair: New Market Making Agreements

Icelandair Group hf. (“Icelandair”) has entered into an agreement with Íslandsbanki hf. for market making of shares issued by the Company traded on the Nasdaq Iceland Regulated Market. The purpose of the agreement is to maintain the liquidity of Icelandair’s shares, create a market price and the price formation of the shares in the most efficient and transparent manner.  The agreement stipulates that Íslandsbanki shall submit daily bids and offers to buy and sell Icelandair’s shares in the trading system of the Icelandic stock exchange. Each bid and offer must be at least ISK 10,000,000 in nominal value, at a rate set by Íslandsbanki. However, such bids shall not vary by more than 3% from the last transaction price. The bid-ask spreads shall be determined by reference to the stock exchange’s price step table as it stands...

Continue reading

Sydbank share buyback programme: transactions in week 13

        Company Announcement No 09/2024Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk2 April 2024  Dear Sirs Sydbank share buyback programme: transactions in week 13On 28 February 2024 Sydbank announced a share buyback programme of DKK 1,200m. The share buyback programme commenced on 4 March 2024 and will be completed by 31 January 2025. The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the share...

Continue reading

DSV, 1099 – SHARE BUYBACK IN DSV A/S

Company Announcement No. 1099 On 1 February 2024, we initiated a share buyback programme, as described in Company Announcement No. 1087. According to the programme, the company will in the period from 1 February 2024 until 23 April 2024 purchase own shares up to a maximum value of DKK 1,000 million, and no more than 1,700,000 shares, corresponding to 0.78% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.Trading day Number of shares bought back   Average transaction price Amount DKK           Accumulated trading...

Continue reading

Abivax reports 2023 financial results and operational update

Abivax reports 2023 financial results and operational updateRaised EUR 500M in 2023, including a EUR 130M capital increase, two structured debt financing transactions aggregating EUR 150M and EUR 223.3M initial public offering on the Nasdaq Global Market Sufficient funds to finance operations into Q4 2025, including through the announcement of top-line data from the Phase 3 ABTECT induction trials of obefazimod in ulcerative colitis (UC) Implementation of U.S. and European operational infrastructure to progress the Company’s ongoing clinical and preclinical programsPARIS, France, April 2, 2024, 8:30 a.m. CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.